94 related articles for article (PubMed ID: 22239038)
1. Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal.
Pavlov IY; Shihab F; Delgado JC
Clin Lab; 2011; 57(11-12):1027-9. PubMed ID: 22239038
[TBL] [Abstract][Full Text] [Related]
2. The influence of the blood handling process on the measurement of circulating TGF-β1.
Zhao L; Wang L; Ji W; Lei M; Yang W; Kong FM
Eur Cytokine Netw; 2012 Mar; 23(1):1-6. PubMed ID: 22456089
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 in Balkan endemic nephropathy.
Dukanović L; Lezaić V; Miljković D; Momcilović M; Bukvić D; Marić I; Miljković Z; Marinković J; Mostarica-Stojković M
Nephron Clin Pract; 2009; 111(2):c127-32. PubMed ID: 19147994
[TBL] [Abstract][Full Text] [Related]
5. Alterations of urine TGF-beta1 and bFGF following bladder outlet obstruction: a predictor for detrusor contractibility?
Shi B; Zhu Y; Laudon V; Ran L; Liu Y; Xu Z
Urol Int; 2009; 82(1):43-7. PubMed ID: 19172096
[TBL] [Abstract][Full Text] [Related]
6. Implication of co-measured platelet factor 4 in the reliability of the results of the plasma transforming growth factor-beta 1 measurement.
Jeon JH; Kim YS; Choi EJ; Cheon S; Kim S; Kim JS; Jang JS; Ha WS; Park ST; Park CS; Park K; Park BK
Cytokine; 2001 Nov; 16(3):102-5. PubMed ID: 11741350
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
8. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
[TBL] [Abstract][Full Text] [Related]
9. Gingival crevicular fluid transforming growth factor-beta1 in several forms of periodontal disease.
Gürkan A; Emingil G; Cinarcik S; Berdeli A
Arch Oral Biol; 2006 Oct; 51(10):906-12. PubMed ID: 16787634
[TBL] [Abstract][Full Text] [Related]
10. [Influence of transforming growth factor beta1 on long-term renal allograft function].
Wang PX; Fan MQ; Huang CB; Zhnag GF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1352-5. PubMed ID: 16982454
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
Zhao SQ; Li J; Liu H; Zhang QG; Wang Y; Han DM
Chin Med J (Engl); 2009 Sep; 122(18):2149-54. PubMed ID: 19781301
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment.
Holmdahl L; Kotseos K; Bergström M; Falk P; Ivarsson ML; Chegini N
Surgery; 2001 May; 129(5):626-32. PubMed ID: 11331455
[TBL] [Abstract][Full Text] [Related]
13. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
[TBL] [Abstract][Full Text] [Related]
14. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
[TBL] [Abstract][Full Text] [Related]
15. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
[TBL] [Abstract][Full Text] [Related]
16. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
Burra P; Masier A; Morisco F; Di Leo V; Zorzi M; Senzolo M; Marchini F; Guido M; Canova D; Floreani A; Burroughs AK
Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225
[TBL] [Abstract][Full Text] [Related]
17. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
[TBL] [Abstract][Full Text] [Related]
18. Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
van Waarde MA; van Assen AJ; Kampinga HH; Konings AW; Vujaskovic Z
Anal Biochem; 1997 Apr; 247(1):45-51. PubMed ID: 9126369
[TBL] [Abstract][Full Text] [Related]
19. Circulating transforming growth factor beta1 (TGFbeta1) is elevated by extensive exercise.
Hering S; Jost C; Schulz H; Hellmich B; Schatz H; Pfeiffer H
Eur J Appl Physiol; 2002 Mar; 86(5):406-10. PubMed ID: 11882926
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study.
Flores L; Näf S; Hernáez R; Conget I; Gomis R; Esmatjes E
Diabet Med; 2004 Aug; 21(8):818-22. PubMed ID: 15270783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
